Login / Signup

Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes.

Lauren G KanapkaR Paul WadwaMarc D BretonKatrina J RuedyLaya EkhlaspourGregory P ForlenzaEda CengizMelissa J SchoelwerEmily JostLori CarriaEmma EmoryLiana J HsuStuart A WeinzimerMark D DeBoerBruce A BuckinghamMary OliveriCraig KollmanBetsy B DokkenDaniel CherñavvskyRoy W Becknull null
Published in: Diabetes care (2020)
This further evaluation of the Control-IQ CLC system supports the findings of the preceding RCT that use of a closed-loop system can safely improve glycemic control in children 6-13 years old with type 1 diabetes from the 1st day of use and demonstrates that these improvements can be sustained through 28 weeks of use.
Keyphrases
  • glycemic control
  • type diabetes
  • young adults
  • blood glucose
  • adipose tissue
  • skeletal muscle